the findings suggest that the increase in dopamine receptors ( assessed by spiperone binding ) in schizophrenia is related to the disease process rather than to previous neuroleptic medication , and may be limited to the type of dopamine receptors that bind butyrophenones .
C0037956
spiperone
C0006525
butyrophenones